PHARM-03
(PHARM) Best Pharmacy Abstracts

Track: BMT Pharmacists Conference
Friday, February 28, 2014: 10:15 AM-11:30 AM
Grapevine A (Gaylord Texan)

113
Intravenous (IV) Busulfan (BU) Pharmacokinetics Using Busulfan and Fludarabine (Flu) Conditioning in Institutions Where the Capability of Doing Pharmacokinetics Is Not Present
Zartash Gul, MD, University of Kentucky/Markey Cancer Center; Shaily Arora, PharmD, University of Kentucky; Amber Lawson, PharmD, University of Kentucky; Heidi L Weiss, Professor department of Biostatistics, Markey Cancer Center

Audio File Recorded Presentation
114
Efficacy of Late Hematopoietic Stem Cell Mobilization 35-40 Hours after Administration of Plerixafor
Vikas Bhushan, MD, Texas Oncology, PA; Jennifer Potter, Texas Oncology, PA; Katherine Sellers, Texas Oncology, PA; Marchelle Badon, Medical City Dallas Hospital; Maria Custodio, BSMT, Medical City Dallas Hospital; Diane Ingermann, Medical City Dallas Hospital; Jennifer Kurre, Medical City Dallas Hospital; Arida Lulo, PharmD, Medical City Dallas Hospital; David Samuel, PharmD, Medical City Dallas Hospital

Audio File Recorded Presentation
115
Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants
Ashley Teusink, PharmD, Cincinnati Children's Hospital Medical Center; Alexander Vinks, PharmD, PhD, FCP, Cincinnati Children's Hospital Medical Center; Kejian Zhang, MD, MBA, Cincinnati Childrens Hospital Medical Center; Tsuyoshi Fukuda, PhD, Cincinnati Childen's Hospital Medical Center; Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center; Adam Lane, Cincinnati Children's Hospital Medical Center; Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center; Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center

Audio File Recorded Presentation
112
Population Pharmacokinetic Modeling of Thymoglobulin in Children Receiving Allogeneic Hematopoietic Cell Transplantation (HCT): Towards Individualized Dosing to Improve Survival
Rick Admiraal, MD, University Medical Center Utrecht; Charlotte van Kesteren, PharmD, PhD, University Medical Center Utrecht; Cornelia M Jol-van der Zijde, Leiden University Medical Center; Maarten van Tol, PhD, Leiden University Medical Center; Imke Bartelink, PharmD, PhD, University Medical Center Utrecht; Robbert Bredius, MD, PhD, Leiden University Medical Center; Jaap-Jan Boelens, MD, PhD, University Medical Center Utrecht; Catherijne AJ Knibbe, PharmD, PhD, Leiden Academic Centre for Drug Research

See more of: BMT Pharmacists Conference
<< Previous Session | Next Session >>